Article Text
Therapeutics
REDUCE Randomised controlled trial
Dutasteride reduces incident prostate cancer in men after negative prostate biopsy
Statistics from Altmetric.com
Footnotes
-
Competing interests AV has received about $5000 in consulting fees from Glaxo Smith Kline, the manufacturers of Dutasteride.